Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -37.56 Million CNY | -32.13% |
| 2022 | -28.43 Million CNY | -55.5% |
| 2021 | -18.28 Million CNY | -1947.44% |
| 2020 | 989.72 Thousand CNY | 492.69% |
| 2019 | -252.03 Thousand CNY | 93.56% |
| 2018 | -3.91 Million CNY | 69.99% |
| 2017 | -13.05 Million CNY | -291.55% |
| 2016 | -3.33 Million CNY | 84.33% |
| 2015 | -21.26 Million CNY | -680.71% |
| 2014 | 3.66 Million CNY | 51.52% |
| 2013 | 2.41 Million CNY | 102.83% |
| 2012 | -85.46 Million CNY | -383.52% |
| 2011 | 30.14 Million CNY | 342.57% |
| 2010 | -12.42 Million CNY | 77.13% |
| 2009 | -54.33 Million CNY | -6473.12% |
| 2008 | -826.66 Thousand CNY | -103.23% |
| 2007 | 25.55 Million CNY | 2343.87% |
| 2006 | 1.04 Million CNY | -85.49% |
| 2005 | 7.2 Million CNY | -24.58% |
| 2004 | 9.55 Million CNY | 198.62% |
| 2003 | -9.68 Million CNY | -282.28% |
| 2002 | 5.31 Million CNY | -33.06% |
| 2001 | 7.93 Million CNY | 33.47% |
| 2000 | 5.94 Million CNY | -61.72% |
| 1999 | 15.53 Million CNY | -38.37% |
| 1998 | 25.2 Million CNY | 7.68% |
| 1997 | 23.41 Million CNY | -2.93% |
| 1996 | 24.11 Million CNY | 51.76% |
| 1995 | 15.89 Million CNY | -7.46% |
| 1994 | 17.17 Million CNY | 46.7% |
| 1993 | 11.7 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -10.91 Million CNY | 26.48% |
| 2024 Q3 | 18.31 Million CNY | 235.38% |
| 2024 Q2 | -13.53 Million CNY | -23.95% |
| 2023 Q2 | -12.38 Million CNY | -49.2% |
| 2023 Q1 | -8.3 Million CNY | 76.79% |
| 2023 FY | -37.56 Million CNY | -32.13% |
| 2023 Q3 | -2.03 Million CNY | 83.58% |
| 2023 Q4 | -14.84 Million CNY | -629.98% |
| 2022 Q3 | -8.63 Million CNY | 20.5% |
| 2022 Q1 | -6.4 Million CNY | 64.78% |
| 2022 FY | -28.43 Million CNY | -55.5% |
| 2022 Q4 | -35.77 Million CNY | -314.05% |
| 2022 Q2 | -10.86 Million CNY | -69.53% |
| 2021 FY | -18.28 Million CNY | -1947.44% |
| 2021 Q1 | -5.66 Million CNY | 86.64% |
| 2021 Q2 | -4.65 Million CNY | 17.74% |
| 2021 Q3 | -9.48 Million CNY | -103.52% |
| 2021 Q4 | -18.19 Million CNY | -91.96% |
| 2020 FY | 989.72 Thousand CNY | 492.69% |
| 2020 Q1 | -3.48 Million CNY | -105.75% |
| 2020 Q2 | -7.37 Million CNY | -111.44% |
| 2020 Q3 | -3.43 Million CNY | 53.44% |
| 2020 Q4 | -42.4 Million CNY | -1134.18% |
| 2019 Q3 | -2.55 Million CNY | 68.06% |
| 2019 Q1 | -2.29 Million CNY | 83.45% |
| 2019 Q2 | -7.98 Million CNY | -248.48% |
| 2019 Q4 | 60.73 Million CNY | 2481.45% |
| 2019 FY | -252.03 Thousand CNY | 93.56% |
| 2018 Q1 | -1.13 Million CNY | -981.02% |
| 2018 Q2 | 13.35 Million CNY | 1273.86% |
| 2018 Q3 | -1.54 Million CNY | -111.57% |
| 2018 Q4 | -13.84 Million CNY | -795.9% |
| 2018 FY | -3.91 Million CNY | 69.99% |
| 2017 Q4 | -105.27 Thousand CNY | 97.43% |
| 2017 Q2 | -4.75 Million CNY | -41.76% |
| 2017 Q1 | -3.35 Million CNY | -381.97% |
| 2017 FY | -13.05 Million CNY | -291.55% |
| 2017 Q3 | -4.09 Million CNY | 13.9% |
| 2016 FY | -3.33 Million CNY | 84.33% |
| 2016 Q3 | 6.52 Million CNY | 233.32% |
| 2016 Q2 | -4.89 Million CNY | 20.43% |
| 2016 Q1 | -6.15 Million CNY | 28.72% |
| 2016 Q4 | 1.18 Million CNY | -81.79% |
| 2015 Q1 | -3.31 Million CNY | -349.88% |
| 2015 FY | -21.26 Million CNY | -680.71% |
| 2015 Q4 | -8.63 Million CNY | -30.15% |
| 2015 Q3 | -6.63 Million CNY | -146.87% |
| 2015 Q2 | -2.68 Million CNY | 18.91% |
| 2014 Q4 | 1.32 Million CNY | -70.5% |
| 2014 FY | 3.66 Million CNY | 51.52% |
| 2014 Q1 | -365.72 Thousand CNY | -106.64% |
| 2014 Q2 | -1.79 Million CNY | -390.3% |
| 2014 Q3 | 4.49 Million CNY | 350.67% |
| 2013 FY | 2.41 Million CNY | 102.83% |
| 2013 Q2 | -2.12 Million CNY | -178.57% |
| 2013 Q4 | 5.5 Million CNY | 250.06% |
| 2013 Q3 | -3.67 Million CNY | -73.04% |
| 2013 Q1 | 2.7 Million CNY | 104.69% |
| 2012 FY | -85.46 Million CNY | -383.52% |
| 2012 Q4 | -57.56 Million CNY | -970.52% |
| 2012 Q2 | -17.05 Million CNY | -211.96% |
| 2012 Q3 | -5.37 Million CNY | 68.46% |
| 2012 Q1 | -5.46 Million CNY | -121.55% |
| 2011 Q4 | 25.36 Million CNY | 1766.19% |
| 2011 Q1 | 2.05 Million CNY | 117.51% |
| 2011 Q3 | 1.35 Million CNY | -0.18% |
| 2011 Q2 | 1.36 Million CNY | -33.74% |
| 2011 FY | 30.14 Million CNY | 342.57% |
| 2010 Q1 | 21.52 Thousand CNY | 100.13% |
| 2010 Q2 | 134.54 Thousand CNY | 525.11% |
| 2010 Q3 | -843.57 Thousand CNY | -727.0% |
| 2010 Q4 | -11.73 Million CNY | -1291.59% |
| 2010 FY | -12.42 Million CNY | 77.13% |
| 2009 Q2 | -27.16 Million CNY | -2412.68% |
| 2009 Q3 | -12.06 Million CNY | 55.58% |
| 2009 Q1 | 1.17 Million CNY | 111.93% |
| 2009 FY | -54.33 Million CNY | -6473.12% |
| 2009 Q4 | -16.28 Million CNY | -34.96% |
| 2008 Q1 | 5.95 Million CNY | -52.25% |
| 2008 Q4 | -9.84 Million CNY | -1267.13% |
| 2008 Q3 | -719.99 Thousand CNY | -119.06% |
| 2008 FY | -826.66 Thousand CNY | -103.23% |
| 2008 Q2 | 3.77 Million CNY | -36.62% |
| 2007 Q2 | 6.47 Million CNY | 194.36% |
| 2007 Q4 | 12.48 Million CNY | 184.05% |
| 2007 Q3 | 4.39 Million CNY | -32.19% |
| 2007 Q1 | 2.2 Million CNY | 171.4% |
| 2007 FY | 25.55 Million CNY | 2343.87% |
| 2006 Q1 | 2 Million CNY | 174.82% |
| 2006 FY | 1.04 Million CNY | -85.49% |
| 2006 Q4 | -3.08 Million CNY | -361.29% |
| 2006 Q3 | 1.18 Million CNY | 24.66% |
| 2006 Q2 | 946.62 Thousand CNY | -52.72% |
| 2005 Q3 | 779.97 Thousand CNY | -73.88% |
| 2005 Q1 | 2.7 Million CNY | -45.76% |
| 2005 FY | 7.2 Million CNY | -24.58% |
| 2005 Q2 | 2.98 Million CNY | 10.22% |
| 2005 Q4 | 728.6 Thousand CNY | -6.59% |
| 2004 FY | 9.55 Million CNY | 198.62% |
| 2004 Q4 | 4.99 Million CNY | 624.46% |
| 2004 Q1 | 1.56 Million CNY | 110.33% |
| 2004 Q2 | 2.3 Million CNY | 47.83% |
| 2004 Q3 | 689.58 Thousand CNY | -70.11% |
| 2003 Q2 | 3.14 Million CNY | 43.96% |
| 2003 FY | -9.68 Million CNY | -282.28% |
| 2003 Q4 | -15.11 Million CNY | -15302.34% |
| 2003 Q1 | 2.18 Million CNY | 94.47% |
| 2003 Q3 | 99.4 Thousand CNY | -96.84% |
| 2002 Q3 | 668.7 Thousand CNY | -43.66% |
| 2002 Q4 | 1.12 Million CNY | 67.86% |
| 2002 Q1 | 2.33 Million CNY | -10.81% |
| 2002 FY | 5.31 Million CNY | -33.06% |
| 2002 Q2 | 1.18 Million CNY | -49.19% |
| 2001 FY | 7.93 Million CNY | 33.47% |
| 2001 Q4 | 2.61 Million CNY | 116.6% |
| 2001 Q3 | 1.2 Million CNY | 0.0% |
| 2000 FY | 5.94 Million CNY | -61.72% |
| 1999 FY | 15.53 Million CNY | -38.37% |
| 1998 FY | 25.2 Million CNY | 7.68% |
| 1997 FY | 23.41 Million CNY | -2.93% |
| 1996 FY | 24.11 Million CNY | 51.76% |
| 1995 FY | 15.89 Million CNY | -7.46% |
| 1994 FY | 17.17 Million CNY | 46.7% |
| 1993 FY | 11.7 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.9 Billion CNY | 100.765% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.39 Billion CNY | 101.107% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 788.26 Million CNY | 104.766% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 82.83 Million CNY | 145.352% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 92.565% |
| NanJing Pharmaceutical Company Limited | 1.49 Billion CNY | 102.518% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 114.81 Million CNY | 132.722% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.36 Billion CNY | 102.752% |